18:1 Caproylamine PE
18:1 Caproylamine PE exhibits promising efficacy in pharmaceutical applications, particularly in addressing complex neurological conditions and malignancies like breast cancer. Its role as a therapeutic modality in Alzheimer's disease is of particular interest, highlighting its potential as a multifaceted treatment option for intricate medical conditions.
| Supplier | BOC Sciences |
|---|---|
| Product # | 110796-31-1 |
| Pricing | Inquire |
| Cas | 110796-31-1 |
| Molecular Weight | 857.19 |
| Molecular Formula | C47H89N2O9P |
| Canonical SMILES | CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)([O-])OCCNC(=O)CCCCC[NH3+])OC(=O)CCCCCCCC=CCCCCCCCC |